Nanotechnology for In vivo Targeted siRNA Delivery

被引:30
|
作者
Dahlman, James E. [1 ,2 ,4 ]
Kauffman, Kevin J. [3 ,4 ]
Langer, Robert [1 ,2 ,3 ,4 ]
Anderson, Daniel G. [1 ,2 ,3 ,4 ]
机构
[1] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA
[2] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA
[3] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[4] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
关键词
LIPID-LIKE MATERIALS; RNAI THERAPEUTICS; SYSTEMIC DELIVERY; DRUG-DELIVERY; ASIALOGLYCOPROTEIN RECEPTOR; NANOPARTICLES; GENE; INTERFERENCE; POTENT; VITRO;
D O I
10.1016/B978-0-12-800148-6.00003-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Small interfering RNAs (siRNAs) can specifically inhibit gene expression. As a result, they have tremendous scientific and clinical potential. However, the use of these molecules in patients and animal models has been limited by challenges with delivery. Intracellular RNA delivery is difficult; it requires a system that protects the siRNA from degradative nucleases in the bloodstream, minimizes clearance by the reticuloendothelial system, maximizes delivery to the target tissue, and promotes entry into, and out of, an endocytic vesicle. Despite these barriers, recent data suggest that RNA may be targeted to cells of interest in vivo. Herein we outline strategies for targeted siRNA delivery, and describe how these strategies may be improved.
引用
收藏
页码:37 / 69
页数:33
相关论文
共 50 条
  • [1] Efficient and targeted delivery of siRNA in vivo
    Shim, Min Suk
    Kwon, Young Jik
    FEBS JOURNAL, 2010, 277 (23) : 4814 - 4827
  • [2] Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
    Rozema, David B.
    Lewis, David L.
    Wakefield, Darren H.
    Wong, So C.
    Klein, Jason J.
    Roesch, Paula L.
    Bertin, Stephanie L.
    Reppen, Tom W.
    Chu, Qili
    Blokhin, Andrei V.
    Hagstrom, James E.
    Wolff, Jon A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (32) : 12982 - 12987
  • [3] ANGIOGENIC VESSEL-TARGETED LIPOSOMES FOR IN VIVO DELIVERY OF SIRNA
    Asai, Tomohiro
    Oku, Naoto
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1149 - 1149
  • [4] Targeted delivery of siRNA
    Oliveira, Sabrina
    Storm, Gert
    Schiffelers, Raymond M.
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2006,
  • [5] NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY
    Allen, T. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 20 - 20
  • [6] Nanotechnology in Targeted Drug Delivery
    Di Stefano, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [7] TARGETED LIPOPLEXES FOR SIRNA DELIVERY
    Cardoso, Ana
    Trabulo, Sara
    Moreira, Joao Nuno
    Duezguenes, Nejat
    Pedroso de Lima, Maria C.
    METHODS IN ENZYMOLOGY LIPOSOMES, PT G, 2009, 465 : 267 - 287
  • [8] In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery
    M Golzio
    L Mazzolini
    A Ledoux
    A Paganin
    M Izard
    L Hellaudais
    A Bieth
    M J Pillaire
    C Cazaux
    J S Hoffmann
    B Couderc
    J Teissié
    Gene Therapy, 2007, 14 : 752 - 759
  • [9] In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery
    Golzio, M.
    Mazzolini, L.
    Ledoux, A.
    Paganin, A.
    Izard, M.
    Hellaudais, L.
    Bieth, A.
    Pillaire, M. J.
    Cazaux, C.
    Hoffmann, J. S.
    Couderc, B.
    Teissie, J.
    GENE THERAPY, 2007, 14 (09) : 752 - 759
  • [10] Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA
    Guo, Lu
    Shi, Dandan
    Shang, Mengmeng
    Sun, Xiao
    Meng, Dong
    Liu, Xinxin
    Zhou, Xiaoying
    Li, Jie
    DRUG DELIVERY, 2022, 29 (01) : 316 - 327